|1.||El-Omar, M: 1 article (01/2001)|
|2.||Casadei, B: 1 article (01/2001)|
|3.||Kardos, A: 1 article (01/2001)|
|1.||Hypotension (Low Blood Pressure)
11/01/1968 - "Experimental studies with Xe-133 in basal conditions and during hypotension induced with "Arfonad"]."
01/01/1963 - "[Methods of eliminating complications arising during hypotension caused by Arfonad (experimental study)]."
11/01/1956 - "[Critical study of 40 cases of hypotension induced by arfonad in neurosurgery]."
03/01/1994 - "In dogs, the resonance gain increases slightly during baroreceptor unloading (mild hypotension obtained with nitroglycerine (NTG) i.v. infusion, n = 8) and coronary artery occlusion ((CAO), n = 6), and it is abolished by ganglionic transmission blockade ((ARF), Arfonad i.v. infusion, n = 3). "
05/01/1986 - "When induction of haemorrhagic hypotension was combined with ganglionic blockade administration (Arfonad) and carotid artery occlusion (group ABC), significantly less blood had to be withdrawn than in groups BC (1.6 +/- 0.2 vs. 2.6 +/- 0.1 ml per 100 g body wt; P less than 0.05). "
05/01/1957 - "An experimental study of arfonad in hemorrhagic shock in dogs."
08/01/1964 - "TRIMETHAPHAN CAMSYLATE IN HEMORRHAGIC SHOCK."
|3.||Hypertension (High Blood Pressure)
03/01/1996 - "To ascertain the optimal dose of trimethaphan camsylate administered by intravenous (i.v.) bolus injection for the control of hypertension and tachycardia during electroconvulsive therapy (ECT). "
01/01/1996 - "Trimethaphan camsylate is a potent antihypertensive drug used to induce systemic arterial hypotension in patients undergoing major surgery and to treat severe systemic hypertension. "
07/01/1976 - "Respiratory paralysis during treatment of hypertension with trimethaphan camsylate."
07/31/1971 - "[Prognostic value of the Arfonad hypotension test in nephrovascular hypertension]."
04/01/1986 - "[A comparison between nicardipine hydrochloride (YC-93) and trimethaphan camsylate for treatment of acute hypertension during surgery. "
|4.||Ganglion Cysts (Ganglion)
05/01/1973 - "[The effect of arfonad on the transmission of excitation in the intracradiac ganglion]."
11/18/1956 - "[Effects of a synthetic ganglion blocking agent derived from thiophanium (arfonad) on visceral circulation]."
10/01/1954 - "[Controlled hypotension with arfonad, a ganglion blocking agent with temporary action; first clinical results]."
01/01/2001 - "To test this hypothesis, we examined the HRV spectral power in 20 patients with mild chronic heart failure (CHF) and 11 controls before and during ganglion blockade with trimethaphan camsylate (3-6 mg/min iv). "
07/01/1984 - "Acute hypotension was produced in rats by using two experimental techniques: intravenous infusion of a ganglion-blocking agent (Arfonad), and venesection of a femoral vein. "
05/01/1965 - "CONTROL OF EXPERIMENTAL HEMORRHAGE WITH ARFONAD."
02/15/1957 - "Arfonad in hemorrhage."
04/01/1956 - "[Arfonad as emergency medicament in massive hemorrhages]."
09/01/1981 - "Trimethaphan camsylate is useful in preventing hemorrhage secondary to a dissecting aneurysm; the other drugs may worsen the tear. "
05/01/1981 - "The effects of graded systemic hypotension induced by the combination of bleeding and trimethaphan camsylate infusion on brain metabolism were studied in normotensive rats (NTR) and spontaneously hypertensive rats (SHR). "
|1.||trimethaphan camsylate (Arfonad)
|4.||Nitroprusside (Sodium Nitroprusside)
|5.||Histamine (Histamine Dihydrochloride)
|7.||Serotonin (5 Hydroxytryptamine)